[HTML][HTML] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang… - European …, 2022 - Eur Respiratory Soc
Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

[PDF][PDF] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang, A Khattab… - Eur Respir J, 2022 - qdcxjkg.com
Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang… - European …, 2021 - Eur Respiratory Soc
Background To gain a global perspective on short-acting β 2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, D Price, HC Wang… - European …, 2022 - abdn.elsevierpure.com
Background: To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang… - The European …, 2022 - pubmed.ncbi.nlm.nih.gov
Background To gain a global perspective on short-acting β 2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

[PDF][PDF] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, D Price, HC Wang, A Khattab… - European Respiratory …, 2022 - aura.abdn.ac.uk
Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

[HTML][HTML] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang… - The European …, 2022 - ncbi.nlm.nih.gov
Background To gain a global perspective on short-acting β 2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.

ED Bateman, DB Price, HC Wang… - The European …, 2022 - europepmc.org
Background To gain a global perspective on short-acting β 2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

[PDF][PDF] Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

ED Bateman, DB Price, HC Wang, A Khattab… - Eur Respir J, 2022 - qdcxjkg.com
Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …